HCA Healthcare, Inc. $HCA Shares Sold by Aware Super Pty Ltd as trustee of Aware Super

Key Points

• Aware Super reduced its HCA Healthcare position by 25.9% in the third quarter, selling 26,092 shares and retaining 74,701 shares valued at approximately $31.9 million. Institutional investors collectively own 62.73% of HCA.
• HCA reported quarterly EPS of $7.22, beating estimates of $6.65, while revenue reached $19.85 billion, up 3.6% year over year and above expectations.
• HCA announced a quarterly dividend of $0.78 per share, equivalent to an annualized $3.12 dividend and a 0.7% yield. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $479.48.

Aware Super Pty Ltd as trustee of Aware Super reduced its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 25.9% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 74,701 shares of the company's stock after selling 26,092 shares during the period. Aware Super Pty Ltd as trustee of Aware Super's holdings in HCA Healthcare were worth $31,878,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. BlackRock Inc. purchased a new position in HCA Healthcare during the 2nd quarter worth $5,069,974,000. Wellington Management Group LLP raised its stake in HCA Healthcare by 20.5% in the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company's stock valued at $1,835,397,000 after buying an additional 799,761 shares during the last quarter. Darsana Capital Partners LP boosted its holdings in HCA Healthcare by 46.7% in the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company's stock worth $428,879,000 after acquiring an additional 350,000 shares in the last quarter. Legal & General Group Plc acquired a new stake in HCA Healthcare in the second quarter worth about $410,992,000. Finally, Jupiter Topco LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth about $371,138,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

HCA stock opened at $467.89 on Tuesday. The company has a market capitalization of $101.30 billion, a P/E ratio of 15.46, a price-to-earnings-growth ratio of 1.53 and a beta of 1.10. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The firm's fifty day simple moving average is $438.21 and its 200-day simple moving average is $444.84.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.65 by $0.57. The firm had revenue of $19.85 billion during the quarter, compared to analysts' expectations of $19.33 billion. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The firm's revenue was up 3.6% compared to the same quarter last year. During the same quarter last year, the company posted $6.96 earnings per share. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 30.15 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, December 15th. HCA Healthcare's dividend payout ratio (DPR) is 10.34%.

Analyst Upgrades and Downgrades

HCA has been the subject of several research analyst reports. Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a research report on Tuesday, July 14th. Weiss Ratings upgraded shares of HCA Healthcare from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Thursday, October 8th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday. Oppenheimer decreased their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an "outperform" rating for the company in a report on Monday, July 27th. Finally, Sanford C. Bernstein reiterated a "market perform" rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $479.48.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Wells Fargo raised its price target for HCA from $381 to $468 while maintaining an “equal weight” rating. The higher target reflects improved valuation support, although the rating signals limited expected upside at current levels. Wells Fargo HCA price-target update
• Positive Sentiment: HCA’s price target was also raised to $521 in a separate analyst update, while KeyCorp reportedly strengthened its earnings-per-share estimates. These revisions may support investor confidence in the company’s earnings outlook. HCA price target raised to $521 KeyCorp HCA EPS estimate update
• Neutral Sentiment: An HCA subsidiary is planning a senior-notes offering. The financing could provide capital for operations or investment, but it would also increase debt obligations; terms such as pricing and size will determine the ultimate impact. HCA subsidiary senior-notes offering HCA senior notes offering
• Neutral Sentiment: HCA released renderings for a planned $300 million hospital in Cape Coral, Florida, with tax support. The project points to long-term expansion but may require substantial capital before contributing meaningfully to earnings. HCA Cape Coral hospital project
• Negative Sentiment: A reported HCA data breach affected approximately 55,000 people, creating potential costs related to remediation, regulatory scrutiny and reputational damage. HCA data breach
• Negative Sentiment: Reports warn of payer pressure ahead of HCA’s 2027 outlook. Concerns over reimbursement rates and negotiations could weigh on margins and temper the benefit of stronger earnings estimates. HCA payer pressure outlook

HCA Healthcare Company Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women's and children's services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.